FTLF

SEC Filing Summary: Bond Laboratories, Inc. (10-Q)

Business Context and Reporting Period

This Form 10-Q covers the quarterly period ended September 30, 2008, and the nine-month period ended on the same date. Bond Laboratories, Inc. (trading as BNLB on OTC:BB) is a small business issuer focused on developing and marketing fortified foods and beverages, specifically targeting energy drinks, pain relief, and weight loss categories. The company operates through a wholly-owned subsidiary, Got Fusion, Inc., and contracts out manufacturing to maintain low overhead. As of November 11, 2008, there were 24,195,706 shares of common stock outstanding.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Revenue increased dramatically from $2,114 in the three months ended Sept 30, 2007, to $501,290 in the same period in 2008. For the nine-month period, revenue rose from $3,119 to $1,126,659, driven by the launch and sales of the "Fusion" energy shot.
• Operating Expenses: Selling and marketing expenses surged from $47,263 (3-month 2007) to $890,485 (3-month 2008). This increase is attributed to hiring investor relations and marketing firms, advertising, and significant stock-based compensation for sponsorships (680,000 shares issued for sponsorship valued at $1.00/share).
• Net Loss: The net loss widened significantly due to heavy investment in marketing and product development. The nine-month net loss increased from $(870,353) in 2007 to $(3,709,622) in 2008.
• Liquidity: Cash balances increased from $590,197 at year-end 2007 to $1,490,068 at Sept 30, 2008, primarily due to financing activities.

Guidance, Outlook, and Risks

Management Commentary & Outlook: Management states that the company has over 18 months of working capital based on a monthly cash requirement of approximately $125,000. The company anticipates that the recent acquisition of NDS Nutritional Products, Inc. (closed Oct 1, 2008) will immediately add significant revenue and be accretive to earnings in the following year. The strategy involves leveraging the NDS distribution network in health and nutrition channels alongside the existing convenience store network.

Subsequent Events: On October 1, 2008, the company acquired assets of NDS Nutritional Products, Inc. Consideration included $700,000 cash, secured promissory notes totaling $350,000 plus book value of fixed assets and inventory, an earn-out of $350,000, and the issuance of 1,550,000 shares of common stock.

Risks and Contingencies:

• Penny Stock Regulation: The stock is subject to Section 15(g) and Rule 15g-9, limiting liquidity and imposing sales practice requirements on broker-dealers.
• Competition: The energy drink market is highly competitive with major players like Red Bull, Monster, and RockStar. The company faces risks regarding market share and pricing pressure.
• Internal Controls: The company acknowledges a lack of segregation of duties and an independent audit committee due to its small size, though management deems the risk low.
• Capital Dependence: Future success depends on the ability to secure additional funding and effectively introduce products to target consumers.

Investor Verification Checklist

• Revenue Quality: Verify the sustainability of the revenue spike from $2k to $500k and the collectibility of the $315,373 in accounts receivable.
• Stock-Based Compensation: Review the valuation of shares issued for services and sponsorships (e.g., 1.2M shares issued for services in Q3 2008) to ensure fair value accounting.
• Acquisition Integration: Assess the financial impact and integration progress of the NDS Nutritional Products acquisition, including the $700k cash outlay and earn-out obligations.
• Cash Burn Rate: Confirm the $125,000 monthly cash requirement against actual operating cash outflows to validate the "18 months of runway" claim.
• Liquidity Constraints: Evaluate the impact of "penny stock" regulations on the ability to raise future capital or for shareholders to exit positions.